Data / Form D filings / Confluence Pharmaceuticals LLC
Confluence Pharmaceuticals LLC: Form D filings
Confluence Pharmaceuticals LLC, a pharmaceuticals company in Carmel, IN, filed 2 Form D notices with the SEC between 2016 and 2018. The latest, on October 4, 2018, reports $10,000 sold of a $800,000 offering to 1 investor.
Find out what Confluence Pharmaceuticals LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4904 DEER RIDGE DRIVE SOUTH, Carmel, IN, 46033
- Phone
- (317) 379-7498
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Indiana
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1689048
The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 4, 2018 | New notice | $800,000 | $10,000 | $790,000 | 1 | Sep 17, 2018 | sec.gov |
| Nov 7, 2016 | New notice | $1,300,000 | $1,284,998 | $15,002 | 10 | Apr 8, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Phil W. Lodato | Director | |
| Steven L. Johns | Executive Officer, Director | |
| Boyd W. Sturdevant, Jr. | Director |
Every Form D from the week of Oct 1, 2018 · All recent filings in Indiana · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Confluence Pharmaceuticals LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.